Jul 9 |
Eli Lilly awaits head-to-head study on GLP-1s after new report reaffirms superiority
|
Jul 9 |
Why Lilly (LLY) is Poised to Beat Earnings Estimates Again
|
Jul 9 |
Study Shows Lilly's (LLY) Obesity Drug More Effective Than NVO's
|
Jul 9 |
Biden hosts NATO summit, Tesla's rally, oil: Morning Brief
|
Jul 9 |
Lilly’s Mounjaro Beats Novo’s Ozempic in Weight Loss, Study Says. The Stocks Battle It Out.
|
Jul 9 |
Eli Lilly (LLY) to Buy Morphic for $3.2B, Boost IBD Presence
|
Jul 9 |
On Mounjaro, patients lose weight faster than on Ozempic: Study
|
Jul 9 |
What Eli Lilly Is Getting With The Acquisition Of Morphic Holding
|
Jul 9 |
Midday movers: Nvidia, Eli Lilly rise; BP, Novo Nordisk fall
|
Jul 9 |
Stocks Are on a Record-Setting Tear. Where They Go From Here and 4 Other Things to Know Today.
|